| Literature DB >> 16144668 |
Michael Perrotti1, Michael E Moran.
Abstract
The triad of cancer cure, rapid recovery of complete urinary continence, and preservation of sexual function are desirable in the contemporary surgical treatment of the young potent male with prostate cancer. Robotic prostatectomy is a Food and Drug Administration approved approach to radical prostatectomy, and is performed at our institution and elsewhere. We present a critical assessment of reported outcomes using this minimally invasive technique.Entities:
Mesh:
Year: 2005 PMID: 16144668 DOI: 10.1016/j.urolonc.2005.02.002
Source DB: PubMed Journal: Urol Oncol ISSN: 1078-1439 Impact factor: 3.498